首页> 美国卫生研究院文献>Haematologica >Comment on Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed Haematologica 2011;96(12):1779–82

【2h】

Comment on Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed Haematologica 2011;96(12):1779–82

机译：评论第二代酪氨酸激酶抑制剂可改善伊马替尼治疗失败的慢性粒细胞白血病患者的生存率Haematologica 2011; 96（12）：1779–82

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Haematologica
作者
Michael Lauseker; Markus Pfirrmann; Verena S. Hoffmann; Joerg Hasford;
展开▼
作者单位

展开▼
年(卷),期 2012(97),5
年度 2012
页码 e14–e15
总页数 2
原文格式 PDF
正文语种
中图分类血液学检验;
关键词
imatinib failure chronic myeloid leukemia second-generation tyrosine kinase inhibitors overall survival;

机译：伊马替尼治疗失败;慢性粒细胞白血病;第二代酪氨酸激酶抑制剂;总生存期;

相似文献

外文文献
中文文献
专利

1. Comment on “Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed” Haematologica 2011;96(12):1779–82 | Haematologica [J] . Michael Lauseker, Markus Pfirrmann, Verena S. Hoffmann, Haematologica . 2012,第5期

机译：评论：“第二代酪氨酸激酶抑制剂可改善伊马替尼治疗失败的慢性粒细胞白血病患者的生存率”，Haematologica 2011; 96（12）：1779–82 |血液学
2. Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed | Haematologica [J] . Amr R. Ibrahim, Richard E. Clark, Tessa L. Holyoake, Haematologica . 2011,第12期

机译：第二代酪氨酸激酶抑制剂可改善伊马替尼治疗失败的慢性粒细胞白血病患者的生存|血液学
3. The achievement of a 3-month complete cytogenetic response to second-generation tyrosine Kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure [J] . JabbourE., KantarjianH., GhanemH., Clinical lymphoma, myeloma & leukemia . 2013,第3期

机译：对第二代酪氨酸激酶抑制剂的3个月完全细胞遗传学反应的实现，预测了伊马替尼治疗失败后的慢性期慢性髓样白血病患者的生存
4. Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S [C] . S. Yamaguchi, M. Sekino, Y. Sato, Intermag Conference . 2006

机译：重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
5. Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed [O] . Amr R. Ibrahim, Richard E. Clark, Tessa L. Holyoake, 2011

机译：第二代酪氨酸激酶抑制剂可改善伊马替尼治疗失败的慢性粒细胞白血病患者的生存率
6. Comment on “Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed” Haematologica 2011;96(12):1779–82 [O] . Lauseker, Michael, Pfirrmann, Markus, Hoffmann, Verena S., 2012

机译：评论“第二代酪氨酸激酶抑制剂可改善伊马替尼治疗失败的慢性粒细胞白血病患者的生存率”，Haematologica 2011; 96（12）：1779–82

Comment on Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed Haematologica 2011;96(12):1779–82

著录项

相似文献

相关主题

期刊订阅